The presence of Parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 1907-1910

  Peterlana, Dimitri ^b   Puccetti, Antonio ^b   Beri, Ruggero ^b   Ricci, Matteo ^b   Simeoni, Sara ^b   Borgato, Lorena ^b   Scilanga, Lucia ^b   Cerù, Silvia ^b   Corrocher, Roberto ^b   Lunardi, Claudio ^a  

^a Section of Internal Medicine   (Italy)

^b NONE

Author keywords

NS1 and VP genes; Parvovirus B19; Rheumatoid synovitis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; JOINT INJURY; MALE; NESTED POLYMERASE CHAIN REACTION; NS1 GENE; OSTEOARTHRITIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE ROUND POLYMERASE CHAIN REACTION; SYNOVITIS; SYNOVIUM; VIRUS GENE; VP GENE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; CAPSID PROTEINS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; GENES, VIRAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOARTHRITIS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; VIRAL NONSTRUCTURAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

EID: 0042694727     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Krause A, Kamradt T, Burmenter GR. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol 1996;8:203-9.
2. Kingsley G. Microbial DNA in the synovium - a role in etiology or a mere bystander? Lancet 1997;349:1038-9.
3. Altschuler EL. Parvovirus B 19 and the pathogenesis of rheumatoid arthritis: a case of historical reasoning. Lancet 1999;354:1026-7.
4. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000;59:1153-6.
5. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR. Bacon PA. Human parvovirus arthropathy. Lancet 1985;23:419-21.
6. Lunardi C,Tiso M, Borgato L, et al. Chronic parvovirus B19 infection induces the production of antibodies with autoantigen binding properties. Eur J Immunol 1998;28:936-48.
7. Soderlund M, Von Essen R, J Arkko H, Urlo K, Kiviluoto O, Klaus H. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997;349:1063-5.
8. Murai C, Munakana Y, Takahashi Y, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999;59:130-2.
9. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227-32.
10. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliot JRM, Mollan RA. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995;34:809-13.
11. Nikkari S, Roivainen A, Hamonen P. et al. Persistence of parvovirus B19 in synovial tissue and bone marrow. Ann Rheum Dis 1995;54:597-600.
12. Ozawa K, Young NS. Characterisation of capsid and noncapsid proteins of B 19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 1987;61:2627-30.
13. Sol N, Junter JLE, Vassias I, et al. Possible interaction between the NS1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by parvovirus B19. J Virol 1999;73:8762-70.
14. Moffatt S, Tanaka N, Tada K. A cytotoxic nonstructural protein, NS1, of parvovirus B19 induces activation of interleukin 6 gene expression. J Virol 1996;70:8485-91.
15. Von Poblotzki A, Hemauer A, Gigler A, et al. Antibodies to nonstructural protein of parvovirus B19 in persistently infected patients: implication for pathogenesis. J Infect Dis 1995;172:1356-9.
16. Kerr JR, Canniffe VS. Antibodies to parvovirus B 19 nonstructural protein are associated with chronic but non acute arthritis following B19 infection. Rheumatology 2000;39:903-8.
17. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Chevrel G, Calvet A, Belin V, Miossec P. Dermatomyositis associated with the presence of parvovirus B 19 DNA in muscle. Rheumatology 2000;39:1037-9.
19. Musiani M, Azzi A, Zerbini M, et al. Nested polymerase chain reaction assay for detection of B 19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol 1993;40:157-60.
20. Cope AP, Jones A, Brozovic M, Shafi MS, Maini RM. Possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis 1992;51:803-4.
21. Ferri C, Zakrzewka K, Longobardo G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999;17:718-20.
22. Nikkari S, Vainionpaa R, Toivanen P. Association of Wegener's granulomatosis with parvovirus B19 infection. Arthritis Rheum 1995;38:1175-6.
23. Hokynar K, Brunstein J, Soderlund-Venermo M. et al. Integrity and full coding sequence of B 19 virus DNA persisting in human synovial tissue. J Gen Virol 2000;81:1017-25.
24. Nikkari S, Vourinen T, Kotilainen P, Lummintausta K. Presence of parvovirus B19 DNA in the skin of healthy individuals. Arthritis Rheum 1999;42:338-40.
25. Loizou S, Cazabon JK, Walport MJ, Tait D. So AK. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997;40:103-8.